FDA approves qualified health claim for high-amylose resistant starch and reduced risk of type 2 diabetes
News that the US Food and Drug Administration (FDA) has approved a qualified health claim about high amylose maize resistant starch as a weapon in the fight against type 2 diabetes will start a much-needed conversation about the fiber, say experts.